Frontlight ResearchEarly access
Chronic kidney disease trials in Slovenia
2 of 4 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Ljubljana
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - No phaseNot yet taking people in SloveniaComparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration
- Where
- Ljubljana
- Age
- 18 years and over
- People
- 20
- Run by
- University Medical Centre Ljubljana
See details and how to joinNCT07618858